Ece Uzun

Dr. Ece Uzun


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
Ece UzunEce Uzun
Ece Uzun
EVEmma W. Viscidi
Emma W. Viscidi
AFAbbie M. Frederick
Abbie M. Frederick
SNShailender Nagpal
Shailender Nagpal
JSJan Stefan Sanders
Jan Stefan Sanders
EMEric M. Morrow
Eric M. Morrow

1 January 2012 in Genomics
Verified
Journal Article
Closed access
Ece UzunEce Uzun
Ece Uzun
QOQing Ouyang
Qing Ouyang
MSMichael Schmidt
Michael Schmidt
SNShailender Nagpal
Shailender Nagpal
EMEric M. Morrow
Eric M. Morrow

20 January 2020 in Autism Research
Verified
Journal Article
Closed access
CMCarolyn E. B. McCormick
Carolyn E. B. McCormick
BKBrian Kavanaugh
Brian Kavanaugh
DSDanielle Sipsock
Danielle Sipsock
GRGiulia Righi
Giulia Righi
LOLindsay M. Oberman
Lindsay M. Oberman
EMEric M. Morrow
Eric M. Morrow

1 July 2015 in Neurotherapeutics
Verified
Journal Article
Open access
PDF file
Ece UzunEce Uzun
Ece Uzun
LSLaura N. Sciarra
Laura N. Sciarra
AMAbbie M. Maguire
Abbie M. Maguire
MPMatthew F. Pescosolido
Matthew F. Pescosolido
LDLaura I. van Dyck
Laura I. van Dyck
EMEric M. Morrow
Eric M. Morrow
Autism spectrum disorder (ASD) is a group of highly genetic neurodevelopmental disorders characterized by language, social, cognitive, and behavioral abnormalities. ASD is a complex disorder with a heterogeneous etiology. The genetic architecture of autism is such that a variety of different rare mutations have been discovered, including rare monogenic conditions that involve autistic symptoms. Also, de novo copy number variants and single nucleotide variants contribute to disease susceptibility. Finally, autosomal recessive loci are contributing to our understanding of inherited factors. We will review the progress that the field has made in the discovery of these rare genetic variants in autism. We argue that mutation discovery of this sort offers an important opportunity to identify neurodevelopmental mechanisms in disease. The hope is that these mechanisms will show some degree of convergence that may be amenable to treatment intervention.

1 April 2013 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
MPMatthew F. Pescosolido
Matthew F. Pescosolido
Ece UzunEce Uzun
Ece Uzun
SNShailender Nagpal
Shailender Nagpal
EMEric M. Morrow
Eric M. Morrow

6 November 2017 in eneuro
Verified
Journal Article
Open access
PDF file
MXMeiyu Xu
Meiyu Xu
QOQing Ouyang
Qing Ouyang
JGJingyi Gong
Jingyi Gong
MPMatthew F. Pescosolido
Matthew F. Pescosolido
BPBrandon Scott PRUETT
Brandon Scott PRUETT
EMEric M. Morrow
Eric M. Morrow
Christianson syndrome (CS) is an X-linked disorder resulting from loss-of-function mutations inSLC9A6, which encodes the endosomal Na+/H+exchanger 6 (NHE6). Symptoms include early developmental delay, seizures, intellectual disability, nonverbal status, autistic features, postnatal microcephaly, and progressive ataxia. Neuronal development is impaired in CS, involving defects in neuronal arborization and synaptogenesis, likely underlying diminished brain growth postnatally. In addition to neurodevelopmental defects, some reports have supported neurodegenerative pathology in CS with age. The objective of this study was to determine the nature of progressive changes in the postnatal brain inNhe6-null mice. We examined the trajectories of brain growth and atrophy in mutant mice from birth until very old age (2 yr). We report trajectories of volume changes in the mutant that likely reflect both brain undergrowth as well as tissue loss. Reductions in volume are first apparent at 2 mo, particularly in the cerebellum, which demonstrates progressive loss of Purkinje cells (PCs). We report PC loss in two distinctNhe6-null mouse models. More widespread reductions in tissue volumes, namely, in the hippocampus, striatum, and cortex, become apparent after 2 mo, largely reflecting delays in growth with more limited tissue losses with aging. Also, we identify pronounced glial responses, particularly in major fiber tracts such as the corpus callosum, where the density of activated astrocytes and microglia are substantially increased. The prominence of the glial response in axonal tracts suggests a primary axonopathy. Importantly, therefore, our data support both neurodevelopmental and degenerative mechanisms in the pathobiology of CS.